Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qutenza for post-surgical neuropathic pain
NL-OMON60444Phase 3Completed
- Sponsor
- Averitas Pharma, Inc.
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of capsaicin in Neuralgia (2 arms), sponsored by Averitas Pharma, Inc. Started Sep 2022; status: completed.
02
Drugs
capsaicin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on NL-OMON60444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60444.